share

3,4-Dehydro Cilostazol-D11 CAS NO 1073608-13-5


Unit Price:

CAS No.:1073608-13-5

Grade:Pharmacy Grade

Content:99.9%

Brand:Customizable

Packaging:Customizable

Description

3,4-Dehydro Cilostazol-D11 is a deuterated analog of a key pharmaceutical intermediate, specifically designed for use as an internal standard in quantitative analytical methods. This high-purity compound is essential for ensuring accuracy and reliability in mass spectrometry and other advanced analytical techniques. It is primarily utilized by pharmaceutical R&D laboratories, contract research organizations (CROs), and quality control departments for method development, validation, and bioanalytical studies.

Application

  • Internal Standard for LC-MS/MS: Critical for the precise quantification of Cilostazol and its metabolites in pharmacokinetic and bioequivalence studies.
  • Pharmaceutical Research & Development: Used in the synthesis and analysis of novel drug candidates and deuterated active pharmaceutical ingredients (APIs).
  • Metabolite Identification & Profiling: Aids in the structural elucidation and tracking of drug metabolites in complex biological matrices.
  • Quality Control & Assurance: Serves as a reference material for ensuring batch-to-batch consistency and purity of non-deuterated Cilostazol intermediates.
  • Regulatory Compliance Testing: Supports analytical methods required for FDA, EMA, and other global regulatory submissions.
  • Stable Isotope Labeling Studies: Enables research into drug metabolism, absorption, distribution, and excretion (ADME) pathways.

Basic Information

Product Name 3,4-Dehydro Cilostazol-D11
CAS No. 1073608-13-5
Molecular Formula C20H16D11N5O2
Molecular Weight ~ 378.55 g/mol
Synonyms 6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dideutero-3,4-dihydro-2(1H)-quinolinone-D9; Deuterated 3,4-Dehydro Cilostazol; Cilostazol Impurity D11; Cilostazol-d11 Derivative; OPC-13013-d11 Derivative; (3,4-Dehydro-6-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]-2(1H)-quinolinone)-D11; 3,4-Dideutero-3,4-dihydrocilostazol-D9
EINECS Contact for details

Quality Control

Every batch of 3,4-Dehydro Cilostazol-D11 is manufactured under controlled conditions and undergoes rigorous analytical testing to ensure the highest standards of chemical purity and isotopic enrichment. Our quality protocols are designed to meet the stringent requirements of analytical reference standard applications. A comprehensive Certificate of Analysis (COA) detailing purity (by HPLC), isotopic purity (by MS), and identity confirmation is provided with each shipment.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). This compound is hygroscopic (moisture-sensitive); the container must be kept tightly sealed in a dry environment to prevent degradation. For long-term storage, consider storing under an inert atmosphere.

Specification

Item Specification
Appearance White to off-white powder
Identification (IR) Conforms to structure
Identification (MS) Conforms to structure
Purity (HPLC) ≥ 98.0%
Isotopic Purity (D-content) ≥ 98.0 atom % D
Water Content (KF) ≤ 0.5%
Residue on Ignition ≤ 0.1%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.

Complete Your RFQ

0/ 2000

Why choose US

Trusted Manufacturer

With our own production facilities, we ensure consistent quality, reliable supply, and full traceability.

Rigorous Quality Assurance

Each batch undergoes strict QC, accompanied by COA, MSDS, and full compliance with international standards.

Advanced R&D Expertise

Our in-house lab drives process innovation, new product development, and tailored synthesis solutions.